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ABSTRACT 
Background 
Emotion regulation refers to the psychological strategies people use to cope with 
stressors such as hemodialysis. These strategies are associated with a range of 
physical and psychological variation that may be related to kidney disease and its 
management. This study explored the associations of two emotion regulation 
strategies, reappraisal and suppression and considered their impact upon patient 
wellbeing and kidney disease management. 
 
Study design 
Cross sectional study. 
 
Setting & Participants: 106 hemodialysis patients undergoing renal replacement 
therapy and 94 friends or relatives. 
 
Predictors 
Reappraisal and suppression, measured with the Emotion Regulation Questionnaire. 
 
Outcomes 
The outcome parameters were measures of affect, psychosocial functioning and 
wellbeing, measured with the Positive and Negative Affect Scale, the Brief COPE 
questionnaire, the Kidney Disease Quality of Life-Short Form and the Brief Symptom 
Inventory. 
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Results 
The Emotion Regulation Questionnaire measured reappraisal and suppression. 
Greater use of reappraisal was associated with lower levels of anxiety (r = -.22, 
p=0.03) and greater acceptance of the disease (r=0.20, p=0.04). It was also associated 
with more experience (r=.26, p=0.007) and expression (r=0.23, p=0.02) of positive 
emotion and less experience (r=-0.35, p=0.001) and expression (r=-0.29, p=0.003) of 
negative emotion. Suppression was associated with less positive emotional expression 
(r=-0.28, p=0.005), higher levels of depression (r=0.22, p=0.03) and somatisation 
(r=0.25, p=0.012) and greater dissatisfaction with the time spent dealing with their 
kidney disease (r=-0.21, p=0.04). Suppression was also associated with less emotional 
coping (r=-0.29, p=0.003) and a greater dissatisfaction with the support received from 
other people (r=-0.34, p=0.001). 
 
Limitations  
The study was focusing on emotion regulation strategies and well being rather than 
clinical parameters therefore extensive medical data not recorded. 
 
Conclusions  
Reappraisal has a range of positive clinical and psychosocial associations in 
comparison to suppression. The emotion regulation strategy used by hemodialysis 
patients has important implications for well-being and disease management. 
 
Keywords: Hemodialysis, kidney disease, end stage renal disease (ESRD), emotion 
regulation, reappraisal, suppression  
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INTRODUCTION  
Background/Rationale 
End stage renal disease (ESRD) and the treatment regimes that accompany it 
challenge the coping abilities of patients and their relatives by requiring them to make 
and maintain many behavioural and lifestyle changes1 . Dialysis regimes are 
significant sources of stress and one study 2 found that over a 1-year period, almost 
10% of patients were admitted to hospital with a psychiatric diagnosis. Particular 
sources of stress include adhering to time consuming treatment schedules, restricting 
dietary and fluid intake and the prescription of multiple medications. Such challenges 
invoke emotional responses such as loss, anxiety and depression and it is common for 
people to regulate their emotions in order to moderate the distress they experience.  
 
Historically, emotions have been viewed as passions that come and go of their own 
accord, however there is growing appreciation that individuals exert considerable 
control over which emotions they have and when they have them3. For example, a 
dialysis patient may hide from others the distress of chronic ill health to avoid 
discussion of its severity. Emotion regulation strategies are believed to be relatively 
stable over time but with insight and social awareness it is possible for people to re-
learn and adjust the emotion regulation strategies they use.At present little is known 
about the impact of chronic disease upon emotion regulation strategies, although it 
may be hypothesised that pre-exisiting strategies would be activated when faced with 
such a stressor.  
 
There are a number of models of emotion regulation, but this study draws upon a 
process model4, as shown in Figure 1. The model proposes emotions may be 
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regulated at five time points during the emotion-generative process. These regulation 
strategies include 1) selection of the situation, 2) modification of the situation, 3) 
deployment of attention, 4) change of cognitions (reappraisal) and 5) the modulation 
of experiential, behavioural or physiological responses (suppression). This study is 
focusing upon reappraisal and suppression as they are considered to be commonly 
used strategies that can be defined in terms of individual differences and they reflect 
both antecedent and response focused strategies. 
 
Reappraisal involves changing how a stressor is construed, for example from “this 
treatment interferes with my whole life” to “this treatment is keeping me as healthy as 
I can be”. Suppression involves hiding distress from others, for example masking 
anxiety with a blank face. There are hypothesised to be 3 associations between 
emotional regulation style and experiential, behavioural and physiological outcomes. 
Gross and John4 operationalised this by using the terms ‘affective functioning’, ‘social 
functioning’ and ‘well-being’. These 3 associations are hypothesised to be positively 
and negatively influenced by reappraisal and suppression respectively5.  
 
Objectives 
Studies of emotion regulation to date have used predominantly undergraduate 
participants4 and experimentally manipulated the use of reappraisal and suppression in 
laboratory settings6,7. As yet, Gross & John’s4 model has not been applied to a clinical 
health population despite emotional suppression playing an important role in 
psychobiological models of disease8.  The aim of this study is to investigate the 
associations between reappraisal and suppression and measures of affect, social 
functioning and well-being. 
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METHODS 
Study design 
The study used a cross-sectional design. Patients were recruited during their regular 
clinic visits on an on-going basis until the sample size was met (see Figure 2). All 
participants were provided with a questionnaire to complete and a brief questionnaire 
for a friend or relative. The patient questionnaire took approximately 25 minutes to 
complete and the relative’s questionnaire approximately 5 minutes.  
 
Setting 
Participants were recruited from renal dialysis units in Glasgow, Scotland. The study 
took place at a single time point between October 2005 and March 2006. The protocol 
and procedures were approved by the North Glasgow University Hospitals Ethics 
Committee and the Greater Glasgow Research and Development Directorate. All 
participants provided written consent prior to beginning the study. 
 
Participants 
Participants were ESRD patients (n=106) who were receiving hospital hemodialysis. 
Inclusion criteria included a diagnosis of ESRD, being able to read English, not 
currently having a functional renal transplant and not receiving home hemodialysis. In 
addition, a friend or relative of each patient was asked to participate in the study 
(n=94). Two hundred questionnaires were handed out and 112 were returned. Six 
were excluded due to large amounts of missing data, which resulted in an analysis rate 
of 95%. Out of the 200 questionnaires handed out, the 106 included questionnaires 
reflected a 53% response rate. Reasons for not taking part included poor eyesight, 
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lack of interest and fatigue. Of those 12 patients who did not get a friend or relative to 
complete a questionnaire, 7 were widowed and 1 was single. This suggests that social 
isolation may have been a reason for non-completion of the relative’s questionnaire. 
 
Variables of interest 
The independent variables were the emotion regulation strategies (reappraisal and 
suppression) and the dependent variables were the measures of affect, social 
functioning and well-being. 
 
Measurement 
Demographic information was acquired from each patient. This included their 
primary renal diagnosis, their age, sex and relationship status. Emotional regulation 
was assessed using the Emotion Regulation Questionnaire (ERQ)4. The ERQ consists 
of 10 statements that assess whether an individual changes the way they think about a 
situation to change how they feel inside, or whether they mask their feelings and 
emotions from others. Test-retest reliability at 3 months is .694. Convergent and 
discriminative validity analyses found that reappraisal was associated with 
reinterpretation (β=.43, p<0.05)* and a sense of being able to regulate mood state 
(β=.20, p<0.05) whereas suppression was associated with feeling inauthentic (β=.47, 
p<0.05) and not venting internal feelings (β=.43, p<0.05)4. Beta values (β) represent 
standardised regression coefficients, in the first example the figure means that a 1 
standard deviation increase in reappraisal leads to 0.43 of a standard deviation 
increase in reinterpretation, indicating that these constructs are closely associated. 
This provides further evidence of the vailidity of the reappraisal construct. Patients 
are asked to rate on a 1 to 7 scale whether they strongly agree or disagree with each 
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statement (1=strongly disagree to 7=strongly agree). Affect was assessed using the 
Positive and Negative Affect Scale (PANAS)9, which measured both the experience 
of emotion (α=.87 positive affect & α=.85 negative affect)2 and the expression of 
emotion (α=.81 positive affect & α=.74 negative affect). In these examples, the 
statistic Alpha (α ) represents the internal consistency of the measure, i.e. how 
strongly does each item correlate with the total score. Measures with α of below 0.6 
are generally considered to have inadequate internal reliability. Further information 
regarding the measures can be found in the Technical Appenidx, Tables A & B.  
The PANAS was also completed by a friend or relative to provide information about 
the patient’s emotional expressive behaviour from other people’s perspectives (α=.88 
positive affect & α=.81 negative affect).  
 
Social functioning was measured using the Brief COPE questionnaire10. The 
subscales included Emotional Support (α=.71), Substance Misuse (α=.90) and 
Behavioural Disengagement (α=.65). Single items from the Kidney Disease Quality 
of Life-Short Form questionnaire (KD-QOL)11 explored perceived burden on others 
and satisfaction with support from family and friends. Single stem questions were 
completed by friends and relatives to explore relationship closeness and peer liking.  
 
Well-being was assessed using the Brief Symptom Inventory12. Internal consistency 
ranged from .74 to .9013. Items from the KD-QOL measured frustration and 
satisfaction with the amount of time spent dealing with their disease.  
 
Sample size 
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The sample size was calculated using Green’s14 formula for testing individual 
predictors (N>104+m). A sample size of 105 was required to obtain power of 0.8. 
 
Statistical methods 
The statistical analysis was carried out using the computer software package SPSS 
version 12.0 (SPSS Inc, Chicago, Illinois). The results are expressed as Pearson’s r 
correlations and p values are reported. Throughout this study, p<0.05 was considered 
statistically significant. Data were grouped by looking at participant scores on both 
subscales of the ERQ rather than by the allocation of participants to either a 
suppression or reappraisal group. Reappraisal and suppression were analysed 
separately as it is possible for individuals to score high on both strategies or low on 
both strategies. In this study we did not classify individuals as either ‘suppressors’ or 
‘reappraisers’ as it is known that people use different emotion regulation strategies at 
different times. Rather, the study sought to explore how the use of the emotion 
regulation strategies were associated with a range of outcomes. Cronbach’s alphas 
were calculated to determine the internal consistency of the subscales used in the 
study and a cut-off of .7 or greater was sought for all those included15.  
 
RESULTS 
Participants  
Of the 106 dialysis patients, 55% were female and the mean age was 64 years (age 
range 19-87 years). Patient characteristics are listed in full in Table 4. Fifty two 
percent were married and 26% were widowed. Diagnoses included Chronic Renal 
Failure (cause unknown) n= 26 (25%), primary glomerular disease n= 20 (19%), 
interstital nephropathy (including polycystic kidney disease) n= 34 (32%), 
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multisystem disease n= 16 (15%) and diabetic nephropathy n= 9 (9%).   The mean 
age of the patients studied and the distribution of primary renal diagnoses were 
representative of the prevalent UK dialysis population16.   
 
Forty two percent of the short questionnaires for friends and relatives were completed 
by a spouse and 21% by a child (see Table 5). Eighty four percent of respondents had 
known the dialysis patient for over 10 years. 
 
Data for the main outcome measures of the study, along with reference data for these 
scales, where available, can be seen in Table 2.  This table provides the means, 
standard deviations and range for each of the scales. In addition Table 2 also makes 
clear the directionality of the scoring, as well as providing some normative data with 
which to compare our results. Examination of Table 2 reveals that our data is similar 
and diverges from previously published reference data in important ways.  Looking 
first at the use of reappraisal, the current study group are similar to the reference 
norms provided by Gross & John, (2003). Looking at use of suppression however, our 
sample of dialysis patients appears to endorse suppression items more highly than the 
refrence group. Our sample also experience lower levels of positive affect and higher 
levels of negative affect than a sample of 1003 community dwelling adults in 
Scotland, reported by Crawford and Henry, (2004).43 Finally, despite these findings, 
our sample’s scores on the BSI subscales also indicates relatively low levels of 
individuals meeting the caseness cut-offs on these scales.   
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Affective correlates of emotion regulation  
Reappraisal of stress early in the emotion generative process was associated with 
greater experience (r=..26, p=0.007) and expression (r=.23, p=0.02) of positive 
emotion and less experience (r=-.35, p=0.004) and expression (r=-.29 p=0.003) of 
negative emotion (see Table 4). Suppression of emotion later in the process was 
associated with less expression (r=-.28, p=0.005) of positive emotion. There was also 
a significant association between friends and relatives reports of patients using 
reappraisal and them expressing less negative emotion (r=-.245, p=0.02). In addition, 
there were positive correlations between patient and relatives report of positive 
(r=.495, p=<0.01) and negative (r=.505, p=<0.01) emotional expression, suggesting a 
level of agreement about emotions being expressed.  
 
Social correlates of emotion regulation 
The reappraisal of stress was not associated with a greater use of emotional coping 
strategies (r=.03, p>0.05) whereas suppression was associated with less use (r=.-29, 
p=0.003). The use of emotional coping strategies was correlated with a number of 
other positive coping techniques including a greater use of self-distraction (r=.294, 
p<0.01), greater use of active coping strategies (r=.324, p<0.01) and more frequent 
use of instrumental coping strategies (r=.571, p<0.01). Suppression was found to be 
associated a greater dissatisfaction with the support received from their family and 
friends (r=.-.33, p=0.001) (see Table 5).  
 
Well-being correlates of emotion regulation  
The cognitive reappraisal of stress was associated with lower levels of anxiety (r=-
.22, p=0.028) and greater levels of acceptance (r=.20, p<0.05) (see Table 6). 
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Acceptance was an important construct as it also correlated with positive reframing 
(r=.419, p<0.01), planning ahead to cope with stressors (r=.427, p<0.01), using 
humour as a coping strategy (r=.279, p=<0.01) and less behavioural disengagement 
(r=-.241, p=0.01).  
 
Surprisingly, suppression of emotion was not associated with higher levels of anxiety 
(r=.13, p=0.18). Suppression was associated with experiencing greater symptoms of 
depression (r=.22, p=0.03) and somatisation (r=.25, p=0.01) and greater 
dissatisfaction with the amount of time spent dealing with their kidney disease (r=-
.21, p=0.04). Self-blame was also correlated with a number of negative constructs. It 
was associated with less positive emotional experience (r=-.355, p<0.01) and 
expression (r=.238, p=0.02) and greater levels of negative emotional experience 
(r=.388, p<0.01) and expression (r=.326, p=<0.01). 
 
Clinical determinants of emotion regulation 
Two multivariate regression analyses were carried out to explore the clinical 
determinants of reappraisal and suppression (See Table 7). The only variable that 
significantly predicted the use of reappraisal was less experience of negative emotion 
(β=.32, p=<0.01). The 2 variables that predicted the use of suppression were less 
experience of positive emotion (β=.23, p=0.05) and less perceived support from 
others (β=.32, p =<0.01). A perception of good social support also predicts less use of 
suppression. Measures of sex, age, marital status, medical diagnosis or length of time 
receiving dialysis did not predict use of either emotion regulation strategy.  
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DISCUSSION 
Key findings 
The associations between emotion regulation and affective, social and well-being 
measures have been well researched in non-clinical samples, but data from 
populations with chronic health problems is limited. This study confirmed that 
reappraisal of stress early in the emotion-generative process is associated with 
positive outcomes for hemodialysis patients. Reappraisal offers protection from 
ongoing and future stressors through positive emotional experiences, stronger social 
support and greater well-being. Suppressing emotion later in the emotion-generative 
process is associated with expressing less positive emotion, poor use of social 
support; feeling unsupported by family and friends, and higher levels of anxiety, 
depression and somatisation.  
 
With regards to affective measures, the study found that reappraisal is associated with 
experiencing and expressing more positive emotion and experiencing and expressing 
less negative emotion. Suppression on the other hand, is associated with less 
expression of positive emotion suggesting that even if the person is feeling in a 
positive mood, they are not showing this to other people. The fact that the study found 
agreement between patient and relatives’ reports of emotional expression suggests 
that the patient’s emotional state and emotion regulation strategies are apparent to 
others. These findings are supported by a study of 49 undergraduate students and 147 
of their peers in which agreement was found between reappraisal and greater 
experience of positive emotion4.  
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The study found that socially, suppression is related to less use of emotional support 
strategies (seeking and accepting support from others) and a greater dissatisfaction 
with the support received from their family and friends. Emotional support has been 
associated with better clinical and functional status 1 year after diagnosis of 
gynaecological cancers17, which suggests there may be clinical implications to not 
using adaptive emotional coping strategies.  
 
These findings are also supported by previous papers that have found suppression to 
impact negatively on relationships with peers4, romantic partners18, and caregivers19. 
In one study17, reappraisal and suppression were manipulated in 86 heterosexual 
couples whilst they discussed a relationship conflict. Memory for conversation 
content was greater for reappraisers than suppressors and suggests that reappraisal 
allows people to focus more on interpersonal situations. Suppressors’ self-monitoring 
of facial expressions and vocal signals distracts them from social interactions and can 
damage relationships. Supportive relationships can protect against distress20, promote 
physical health and well-being21 and help patients to maintain their dietary regime and 
attend clinic appointments22. Social support also correlates with reduced illness 
burden, higher global satisfaction with life and better marital satisfaction23,24.  These 
findings suggest that the social implications of emotion regulation have considerable 
implications for patient well-being and the self- and professional-management of 
kidney disease.  
 
This study also found that reappraisal was associated with lower levels of anxiety and 
a greater acceptance of kidney disease and dialysis treatment. Suppression was 
associated with higher levels of anxiety, depression and somatisation and greater 
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dissatisfaction with the amount of time spent dealing with their disease. Depression 
and anxiety are prevalent problems in the hemodialysis population and reported rates 
of depression range from 13.9%25 to 100%26. Depression can impact upon survival 
and is negatively correlated with quality of life27. Withdrawal of dialysis remains an 
important cause of death in ESRD28 and has been found to be mediated in part by 
depressive symptoms29. This again suggests that suppressing emotions can have 
potentially serious implications for individuals. 
 
Studies into the physical implications of emotion regulation and emotional expression 
have found them to have important roles in psychosomatic models of disease. 
Previous research suggests that active suppression of strong emotions can increase 
one’s susceptibility to illness30. A meta-analysis found emotional expression to be 
implicated in the course of coronary heart disease, asthma and arthritis31 and the 
suppression of emotions to be involved in cancer onset and progression32,33. Denollet 
et al 34 divided heart attack survivors in to 4 groups based on measures of distress and 
suppression of emotion. The group scoring highest on levels of distress and 
suppression had a significantly higher death rate (27%) than other groups (7%). Other 
studies manipulated the use of emotion regulation strategies and found them to be 
malleable and to have physiological consequences. They identified changes in 
somatic response, skin conductance, respiratory and cardiovascular activity 35 6 . 
 
The findings from this study have clinical relevance in identifying that emotion 
regulation strategies are associated with a range of important clinical and social 
parameters. Administration of the ERQ could identify those patients who are 
suppressing their emotions, initiate a referral to psychological services and form a 
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framework on which to focus treatment. The cognitive-behavioural basis of 
reappraisal and suppression fits with current psychological models of coping and 
adjustment to chronic medical problems, and would be amenable to evidence-based 
psychological treatment packages36. A previous study explored the clinical efficacy of 
emotion regulation therapy and found that compared to the control group, a 
supportive-expressive group for women with metastatic breast cancer resulted in a 
decrease in the suppression of negative affect at 1 yr follow-up37. In addition, a case 
study found that emotion regulation therapy successfully treated the symptomatic, 
functional and qualitative aspects of Generalised Anxiety Disorder38.  
 
Based on these findings, further research could investigate the potential of 
psychological interventions to promote reappraisal in a dialysis population. The long-
term implications of changing to a reappraisal strategy could then be assessed and its 
outcomes measured. With regards to generalizability, the findings of this study may 
also have clinical value for other populations with chronic health problems such as 
diabetes or Chronic Obstructive Pulmonary Disease. 
 
Limitations  
The findings of this study must be interpreted in the context of its limitations. 
Primarily this paper was looking at emotion regulation strategies and well being rather 
than clinical parameters therefore extensive medical data not recorded. In addition, 
the information was collected by self-report, which depending on the subject area, can 
be prone to inaccuracies as a result of poor understanding or discomfort with self-
disclosure. As suppression is associated with being less likely to report negative 
emotions, it may make the results of this study more representative of a reappraisal 
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sample. It is also possible that the questionnaire for friends and relatives deterred 
those who were socially isolated from participating. Finally, the 53% response rate 
may have introduced bias with potentially less responders in the suppression group 
and as a result, fail to reflect the opinions of the whole population. However, 
triangulation with other dialysis papers39,40,41,42revealed similar response rates and 
patient characteristics to this study. 
 
Interpretation 
In this hemodialysis population, reappraisal was associated with greater levels of 
positive affect, better social functioning and greater well-being than suppression. This 
has important physical, social and psychological implications for a population with 
chronic medical problems and warrants further research into the long effects of 
emotion regulation and the ability of psychological interventions to moderate them. 
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TABLE 1: Demographic information: hemodialysis patients 
 
Characteristics     n %  mean range standard 
                                                             deviation 
Sex 
  Male      48 45.3 
  Female     58 54.7 
Age (years)       64 19-87 15.1 
Relationship status 
  Married     55 51.9  
  Widowed     27 25.5 
  Single     12 11.3 
  Partner     8 7.5 
  Divorced     4 3.8 
Primary Renal Diagnoses 
  Chronic Renal failure: cause unknown 26 25 
  Primary Glomerular Disease  20 19 
  Interstitial Nephropathy   34 32 
  Multisystem Disease    16 15 
  Diabetic Nephropathy    9  9 
Time receiving dialysis (months)    50 1-444 
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TABLE 2: Statistics for all scales used 
 
Scale Mean SD Min 
value 
Max 
value 
Direction Reference Values 
 
Mean       SD 
Emotion Regulation 
Questionnaire 
Reappraisal 
4.84 1.14 1 7 Higher score 
= more 
agreement 
4.6 0.98 
Emotion Regulation 
Questionnaire 
Suppression 
4.73 1.3 1 7 Higher score 
= more 
agreement 
3.39 1.15 
Positive & 
Negative Affect 
Scale 
Positive experience 
28.9 9.4 11 48 Higher score 
= more 
experience 
31.3* 7.65* 
Positive & 
Negative Affect 
Scale 
Negative 
experience 
21.9 8.4 10 44 Higher score 
= more 
experience  
16.0* 5.9* 
Positive & 
Negative Affect 
Scale 
Positive expression 
27.7 9.9 10 47 Higher score 
= more 
expression 
Normative  data not 
available  
Positive & 
Negative Affect 
Scale 
Negative 
expression 
19.0 7.4 10 39 Higher score 
= more 
expression 
Normative  data not 
available 
Positive & 
Negative Affect 
Scale 
Positive expression 
– other rated 
30.9 9.1 10 47 Higher score 
= more 
expression 
Normative  data not 
available 
Positive & 
Negative Affect 
Scale 
Negative 
expression – other 
rated 
21.1 8.8 10 50 Higher score 
= more 
expression 
Normative  data not 
available 
Brief COPE  
Emotional coping 
5.2 2.0 2 8 Higher score 
= greater use 
of coping 
strategy 
5.75 1.44 
Kidney Disease 
Quality of Life 
Support from 
family and friends 
2.4 .87 0 3 Higher score 
= greater 
satisfaction 
with support 
Normative  data not 
available 
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Brief Symptom 
Inventory  
Somatisation 
7.3 4.4 0 19 Higher score 
= more 
somatisation  
Males: >10 
indicates caseness 
Females: >13 
indicates caseness 
 
Brief Symptom 
Inventory  
Depression 
5.7 5.3 0 23 Higher score 
= greater 
levels of 
depression  
Males: >10 
indicates caseness 
Females: >13 
indicates caseness 
Brief Symptom 
Inventory  
Anxiety 
5.9 5.1 0 21 Higher score 
= greater 
levels of 
anxiety 
Males: >10 
indicates caseness 
Females: >13 
indicatescaseness 
Brief COPE  
Acceptance 
6.1 2.0 2 8 Higher score 
= greater use 
of coping 
strategy 
5.92 1.28 
Kidney Disease 
Quality of Life 
Too much time is 
spent dealing with 
my disease 
5.8 4.5 0 16 Higher score 
= greater 
disagreement 
with 
statement 
Normative  data not 
available 
* These data are from a large UK based non-clinical sample: Crawford and Henry, 
(2004). 
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TABLE 3: Demographic information: friends and relatives 
 
Characteristics    n  %     
Relationship to hemodialysis patient 
  Spouse    46  48.9 
  Child     22  23.4 
  Friend    8  8.5 
  Parent    7  7.4 
  Sibling    6  6.4 
  Partner    5  5.4 
Length of time known patient  
  1-4 years    2  1.9 
  5-9 years    3  2.8 
  10-14 years    2  1.9 
  15-19 years    7  6.6 
  20-24 years    6  5.7 
  25-29 years    4  3.8 
  30-34 years    9  8.5 
  35 years +     61  57.5 
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TABLE 4:  Associations between reappraisal and suppression and affect 
 
 
 
         Emotion regulation strategy       
    Reappraisal  Suppression 
    r p  r p 
Positive emotion 
Experience 
  Mood (PANAS)  .26 0.007*  -.20 0.04 
Expression 
  Self reported   .23 0.02*  -.28 0.005* 
 
Negative emotion 
Experience    
  Mood (PANAS)   -.35 <0.001*  .10 0.27 
Expression 
  Self-reported   -.29 0.003*  -.05 0.96 
  Peer-rated   -.24 0.02*   .00 0.30 
 
*p<0.05 
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TABLE 5: Associations between reappraisal and suppression and social functioning 
 
        Emotion regulation strategy    
    Reappraisal     Suppression 
    r p  r p 
Social support 
  Brief COPE: Emotional .14 0.17     -.29 0.003* 
 
Kidney Disease Quality of Life Scale 
  Support from others  -.003   0.98  -.33 0.001* 
      * p≤.05 
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TABLE 6: Associations between reappraisal and suppression and well-being 
 
         Emotion regulation strategy    
    Reappraisal  Suppression 
    r p  r p 
Brief Symptom Inventory 
  Anxiety   -.22 0.03*  .13 0.18 
  Depression   -.22 0.03*  .22 0.03* 
  Somatisation   -.06 0.53  .25 0.012* 
 
Brief COPE 
    Acceptance   .20 0.05*  .15 0.14 
 
Kidney Disease Quality of Life Scale 
    Time spent on disease -.07 0.48  -.21 0.04* 
* p≤.05 
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TABLE 7: Determinants of Emotion Regulation 
           Emotion regulation strategy    
Step Variables Entered   Reappraisal  Suppression 
      Beta p  Beta p 
1 Experience of positive emotion -.10 .35  .23 .05* 
 Experience of negative emotion .32 .004*  .01 .94 
 
2 BSI Somatisation   -.16 .21  -.24 .08 
 BSI Depression   .01 .95  -.18 .32 
 BSI Anxiety    .07 .69  .19 .29 
 
3 Brief COPE: Acceptance  -.15 .18  -.02 .89 
 Support from Others   .13 .21  .32 .002* 
 
4 Length of Time on Dialysis  .-06 .56  -.16 .10 
 Diagnosis    .04 .68  .13 .19 
 
5 Sex     -.08 .41  .05 .62 
 Age     .13 .33  -.21 .09 
 Relationship Status   -.12 .32  -.15 .21 
* p≤.05 
 
 
 
 
 
 
 
 
 
 
 
 
   33 
                                                                                                                                            
 
LEGENDS 
 
FIGURE 1: A process model of emotion regulation describing 5 antecedent and 
response focused strategies (Gross, 2002)  
 
According to this model, emotion may be regulated at five time points in the emotion-
generative process: (a) selection of the situation, (b) modification of the situation, (c) 
deployment of attention, (d) change of cognitions, and (e) modulation of experiential, 
behavioral, or physiological responses.  The first four of these processes are 
antecedent-focused and the fifth is response-focused. The number of response options 
shown at each of these five points in the illustration is arbitrary, and the heavy lines 
indicate the particular options selected. 
Reprinted from “Emotion Regulation in Adulthood: Timing Is Everything,” by J. J. 
Gross, 2001, Current Directions in Psychological Sciences, 10, p. 215. Copyright 
2001 by Blackwell Publishers. Reprinted with permission. 
 
 
 
FIGURE 2: Selection and recruitment of participants 
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TECHNICAL APPENDIX 
 
TABLE A: Sample Characteristics, Varimax Rotated Factor Loadings for the 10 
Items on the Emotion Regulation Questionnaire, Alpha Reliability, and Scale 
Intercorrelations in Four Samples  
Sample 
A     B     C     D 
Sample characteristics 
Sample size        791  336  240  116 
Mean age (years)       20  20  20  18 
% women        67  63  50  64 
% African American       05  04 02  03 
% Asian American       41  40  24  26 
% European American      28  33  56  55 
% Latino        09  16  15  09 
 
Reappraisal factor 
1. I control my emotions by changing the way I think  
about the situation I’m in.     .66  .76  .73  .82 
2. When I want to feel less negative emotion, I change  
the way I’m thinking about the situation.    .83  .73  .82  .85 
3. When I want to feel more positive emotion, I change  
the way I’m thinking about the situation.    .83  .77  .80  .84 
4. When I want to feel more positive emotion (such as  
joy or amusement), I change what I’m thinking about.  .71  .75  .55  .49 
5. When I want to feel less negative emotion (such as  
sadness or anger), I change what I’m thinking about.  .68  .76  .62  .67 
6. When I’m faced with a stressful situation, I make  
myself think about it in a way that helps me stay calm.  .55  .32  .48  .71 
Highest of all cross loadings (absolute values)   .14  .14  .15  .13 
Internal consistency (alpha)     .80  .77  .75  .82 
 
Suppression factor 
7. I control my emotions by not expressing them.   .83  .78  .85  .89 
8. When I am feeling negative emotions, I make sure  
not to express them.       .76  .73  .73  .69 
9. I keep my emotions to myself.     .81  .77  .84  .87 
10. When I am feeling positive emotions, I am careful  
not to express them.       .54  .56  .54  .57 
Highest of all cross loadings (absolute values)   .18  .12  .20  .23 
Internal consistency (alpha)     .73  .68  .75  .76 
 
Scale intercorrelation       .06  .01  -.04 -.06 
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Reprinted from Gross JJ, John OP: Individual differences in two emotion regulation 
processes: Implications for affect, relationships and well-being. J Pers Soc Psychol 
85: 348-362, 2003 
  
TABLE B: Description of outcome measures 
 
SCALE    ITEMS   EXAMPLE OF ITEMS 
Brief Symptom Inventory 18 
Depression    6 Feeling hopeless about the future 
Anxiety    6 Nervousness of shakiness inside 
Somatisation    6 Pains in heart or chest 
 
Brief COPE 
Emotional support   3 I've been getting emotional support from  
      others 
Acceptance    3 I've been accepting the reality of the fact  
      that it has happened 
 
POSITIVE AND NEGATIVE AFFECT SCALE 
Positive experience   10 Strong 
Negative experience   10  Guilty 
Positive expression   10 Proud 
Negative expression   10 irritable 
 
KIDNEY DISEASE QUALITY OF LIFE-SHORT FORM 
Support from others   1 The support you receive from your  
      family and friends  
Time spent dealing with disease 1 Too much time is spent dealing with my  
  kidney disease 
 
SINGLE STEM QUESTIONS 
Likeability    1 X is the kind of person almost everybody  
      likes 
Enjoy spending time with  1 X has close relationships with others 
 
 
 
